carbapenems has been researched along with cefoxitin in 22 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (cefoxitin) | Trials (cefoxitin) | Recent Studies (post-2010) (cefoxitin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 2,131 | 362 | 328 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 5 (22.73) | 2.80 |
| Authors | Studies |
|---|---|
| Hopkins, JA; Lami, JL; Wilson, SE | 1 |
| Danel, F; Livermore, DM; Villar, HE | 1 |
| Ardanuy, C; Benedí, VJ; Domínguez, MA; Hernández-Allés, S; Liñares, J; Martínez-Martínez, L | 1 |
| French, GL; Shannon, KP; Stapleton, PD | 1 |
| Hashimoto, K; Ito, K; Ogata, H | 1 |
| Jacoby, GA; Walker, VJ; Walsh, KE | 1 |
| Albertí, S; Doménech-Sánchez, A; García-Sureda, L; Juan, C | 1 |
| Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E | 1 |
| Coffin, SE; Feng, R; Haynes, K; Kronman, MP; Zaoutis, TE | 1 |
| Chiu, SK; Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL; Yeh, KM | 1 |
| Ji, Y; Jiang, Q; Li, K; Mi, Z; Shi, M; Shi, W; Wang, Y | 1 |
| Bille, E; Emirian, A; Groh, M; Guet-Revillet, H; Join-Lambert, O; Jullien, V; Nebbad-Lechani, B; Weiss, E; Zahar, JR | 1 |
| Carbonnelle, E; Compain, F; Geri, G; Kernéis, S; Lavollay, M; Mainardi, JL; Rostane, H; Valade, S | 1 |
| Anh, NQ; Kirikae, T; Miyoshi-Akiyama, T; Nhung, PH; Ohmagari, N; Phuong, DM; Shimada, K; Tada, T | 1 |
| Brook, I | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Avison, MB; Takebayashi, Y; Taylor, ES; Whitwam, S | 1 |
| Fihman, V; Lafaurie, M; Lepeule, R; Lescure, X; Lesprit, P; Nguyen, Y; Oubaya, N; Senard, O; Therby, A | 1 |
| Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C | 1 |
| Abdulhemid Said, L; Muhsin, EA; Sajid Al-Jubori, S | 1 |
| Banaei, N; Bounthavong, M; Deresinski, S; Diep, C; Ha, D; Lu, B; Wong, M | 1 |
| Bastian, S; Breurec, S; Camous, L; Carles, M; Dequidt, T; Nacher, M; Pommier, JD; Thiery, G; Tressieres, B; Valette, M | 1 |
1 review(s) available for carbapenems and cefoxitin
| Article | Year |
|---|---|
Spectrum and treatment of anaerobic infections.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Carbapenems; Cefoxitin; Chloramphenicol; Clindamycin; Drug Resistance, Bacterial; Humans; Metronidazole; Minocycline; Penicillins; Tigecycline | 2016 |
1 trial(s) available for carbapenems and cefoxitin
| Article | Year |
|---|---|
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins | 1991 |
20 other study(ies) available for carbapenems and cefoxitin
| Article | Year |
|---|---|
Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefoxitin; Cell Membrane Permeability; Imipenem; Mutation; Proteus mirabilis | 1997 |
Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.
Topics: Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Cephamycins; Cross Infection; Disease Outbreaks; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Spain | 1998 |
Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.
Topics: Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporin Resistance; Escherichia coli; Gene Expression Regulation, Bacterial; Plasmids | 1999 |
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary | 2003 |
Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefoxitin; Clavulanic Acid; Edetic Acid; Escherichia coli; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2006 |
Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Cefoxitin; Electrophoresis, Polyacrylamide Gel; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Porins; Thienamycins | 2011 |
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections | 2012 |
Antibiotic exposure and IBD development among children: a population-based cohort study.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Cefoxitin; Child; Child, Preschool; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Inflammatory Bowel Diseases; Logistic Models; Male; Metronidazole; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk; Tetracycline; United Kingdom; Vancomycin | 2012 |
National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefotaxime; Cefoxitin; Ceftazidime; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2013 |
Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefoxitin; China; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Weight; Polymerase Chain Reaction; Porins | 2013 |
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefoxitin; Drug Administration Schedule; Drug Dosage Calculations; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Models, Statistical; Pyelonephritis; Urinary Tract Infections | 2014 |
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Young Adult | 2015 |
IMP-51, a novel IMP-type metallo-β-lactamase with increased doripenem- and meropenem-hydrolyzing activities, in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Topics: beta-Lactamases; Carbapenems; Cefoxitin; Doripenem; Escherichia coli; Meropenem; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 2015 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
CreC Sensor Kinase Activation Enhances Growth of Escherichia coli in the Presence of Cephalosporins and Carbapenems.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cephalosporins; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Protein Kinases; Regulon | 2019 |
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Fever; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Urinary Tract Infections | 2020 |
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Prevalence of Efflux Pump and Porin-Related Antimicrobial Resistance in Clinical
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefepime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Iraq; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Prevalence | 2022 |
Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cefoxitin; Citrobacter freundii; Enterobacter aerogenes; Enterobacter cloacae; Humans; Microbial Sensitivity Tests; Morganella morganii; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Serratia marcescens | 2023 |
Cefoxitin versus carbapenems as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Humans; Klebsiella pneumoniae; Retrospective Studies | 2023 |